FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT<\/p>\n
The Novartis Group is one of the biggest global pharmaceutical and healthcare groups, developing and delivering medical treatments and drugs. The Complainant, with headquarters in Switzerland, was created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, and is the holding company of the Novartis Group.<\/p>\n
In 2024, the Novartis Group achieved net sales of USD 50.3 billion, and total net income amounted to USD 11.9 billion and employed approximately 76 000 full-time equivalent employees as of 31 December 2024. <\/span><\/p>\n The Complainant’s products are manufactured and sold in many countries worldwide including in Australia.<\/p>\n The Complainant owns numerous domain names composed of either its trade mark NOVARTIS alone, including <<\/span>novartis.com> (created on 2 April 1996) or in combination with other terms, such as <<\/span>novartispharma.com> (created on 27 October 1999). The Complainant uses these domain names to resolve to its official websites through which it informs Internet users and potential consumers about its mark and its related products and services.<\/span><\/p>\n The Domain Name was registered on 27 February 2025. <\/span><\/p>\n At the time the Complainant found out about the Domain Name on 11 March 2025, it resolved to a parking page. At the time of filing of this Complaint, the Domain Name still resolved to a parking page. <\/span><\/p>\n On 11 March 2025, the Complainant sent a Cease-and-Desist Letter to the Registrant, through the contact form listed on the publicly available WhoIs records and to the Registrar, asking the latter to forward the letter to the Registrant. In the Cease-and-Desist Letter, the Complainant asserted that the unauthorised use of its trade mark within the Domain Name violated the Complainant's trademark rights and requested a voluntary transfer of the Domain Name. The Complainant further sent a reminder on 21 March 2025, but there was no response. <\/span><\/p>\n <\/p>",
"other_legal_proceedings": " The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name (the \"Domain Name\").<\/p>",
"no_response_filed": " The Complainant contends that the requirements of the Policy have been met and that the Domain Name should be transferred to it.<\/p>\n No administratively compliant Response has been filed.<\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the Domain Name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Domain Name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"Matthew Harris"
],
"date_of_panel_decision": "2025-04-25 00:00:00",
"informal_english_translation": " The Complainant relies upon various trade mark registrations that comprise or incorporate the term \"Novartis\", including:<\/p>\n (i) International trade mark no. 1544148, for NOVARTIS as a word mark, in classes 09, 35, 38, and 42<\/span> with a registration date of 29 June 2020, which has proceeded to registration at least in part in approximately 26 teritories including Australia;<\/p>\n (ii) EU trade mark no. 304857 for NOVARTIS as a word mark, in classes 1, 5, 9, 10, 29, 30, 31 and 32<\/span> with a filing date of 5 July 1996 <\/span>and a registration date of 25 June 1999; and <\/p>\n (iii) US trade mark no. 4986124 for NOVARTIS as a word mark, in classes 5, 9, 10, 41, 42, and 44<\/span> with a filing date of 13 September, 2013<\/span> <\/span>and a registration date of 28 Jun 2016. <\/span> <\/p>\n <\/p>",
"decision_domains": {
"novartisbiotech.com": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}